Completed
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
NCT02649478
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Roxane Laboratories Research Site #30 Glendale, Arizona, United States
- Roxane Laboratories Research Site #46 Phoenix, Arizona, United States
- Roxane Laboratories Research Site #1 Surprise, Arizona, United States
- Roxane Laboratories Research Site #13 Tempe, Arizona, United States